MarketScreener Homepage > Equities > New Zealand Stock Exchange > Fisher & Paykel Healthcare Corporation Limited FPH NZFAPE0001S2

Report

End-of-day quote New Zealand Stock Exchange - 11/24
34	NZD		+3.34%

11/22

Australia shares at near 9-month high as biggest states reopen borders

11/19

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED : half-yearly earnings release

11/13

Australia shares end lower as traders shun risk on virus surge

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote New Zealand Stock Exchang…

11/18/2020	11/19/2020	11/20/2020	11/23/2020	11/24/2020	Date
33.7	33.44	32.66	32.9	34	Last
481327	564634	726634	416802	837382	Volume
-1.46%	-0.77%	-2.33%	+0.73%	+3.34%	Change

Financials

Sales 2021	1 650 M 1 153 M 1 153 M
Net income 2021	398 M 278 M 278 M
Net cash position 2021	67,2 M 46,9 M 46,9 M
P/E ratio 2021	49,2x
Yield 2021	1,17%

Sales 2022	1 660 M 1 160 M 1 160 M
Net income 2022	392 M 274 M 274 M
Net cash position 2022	186 M 130 M 130 M
P/E ratio 2022	50,5x
Yield 2022	1,25%

Capitalization	18 950 M 13 081 M 13 243 M
EV / Sales 2021	11,4x
EV / Sales 2022	11,3x
Nbr of Employees	4 751
Free-Float	99,9%

More Financials

Company

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Companyâ€™s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by...

Sector

Medical Equipment, Supplies & Distribution

Calendar

11/24 | 09:00pm

Ergebnisveröffentlichung

More about the company

Notations Surperformance© of Fisher & Paykel Healthcare Corporation Limited

Trading Rating :

Investor Rating :

More Ratings

All news about FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

11/22	Australia shares at near 9-month high as biggest states reopen borders	RE
11/19	FISHER & PAYKEL HEALTHCARE CORPORATI : half-yearly earnings release
11/13	Australia shares end lower as traders shun risk on virus surge	RE
10/30	Australia shares post biggest weekly drop in 6 months on mixed cues	RE
10/29	Australian shares set for biggest weekly loss since April	RE
10/27	Australian shares inch lower on virus, U.S. stimulus worries	RE
10/22	Australia shares close lower as U.S. stimulus appears elusive	RE
10/15	FISHER & PAYKEL HEALTHCARE : to announce half year results on 25 November 2020	PU
09/22	Australia shares end lower as rising COVID-19 cases stoke lockdown worries	RE
09/21	Australia shares hit over 2-month low as miners drag; U.S. stimulus woes weig..	RE
09/20	Australia shares slip as virus cases resurge in Europe; NZ lower	RE
09/10	Australia shares hit over 2-month low as tensions with China mount	RE
09/03	Australia shares fall sharply on Wall Street tech sell-off	RE
09/02	Australia shares follow Wall Street higher on recovery, stimulus hopes	RE
08/31	Australia shares hit four-week low ahead of cenbank decision	RE

More news

News in other languages on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

11/19	FISHER & PAYKEL HEALTHCARE CORPORATI : publication des résultats semestriels
11/19	FISHER & PAYKEL HEALTHCARE CORPORATI : Veröffentlichung des Halbjahresergebnisse..

More news

Provided by Scoopnest.com

Chart FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

Duration : Period :

Fisher & Paykel Healthcare Corporation Limited Technical Analysis Chart | FPH | NZFAPE0001S2 | MarketScreener

Full-screen chart

Technical analysis trends FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

	Short Term	Mid-Term	Long Term
Trends	Bearish	Neutral	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	UNDERPERFORM
Number of Analysts	9
Average target price	28,68 NZD
Last Close Price	34,00 NZD
Spread / Highest target	10,6%
Spread / Average Target	-15,6%
Spread / Lowest Target	-40,6%

Consensus

EPS Revisions

More Estimates Revisions

Managers

Name	Title
Lewis George Gradon	Chief Executive Officer, Director & MD
Scott Andrew St. John	Chairman
Lyndal York	Chief Financial Officer
Andrew Robert Donald Somervell	Vice President-Products & Technology
Nicholas Fourie	VP-Information & Communication Technology

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	53.15%	13 081



ABBOTT LABORATORIES	25.80%	193 666
MEDTRONIC PLC	-2.19%	149 189
BECTON, DICKINSON AND COMPANY	-15.99%	66 229
HOYA CORPORATION	20.05%	44 928
BAXTER INTERNATIONAL INC.	-9.39%	38 705

More Results